Launch Date
10/23/2026
Credit Amount
0.75
Credit Expires
10/23/2027
Despite major advances in human immunodeficiency virus (HIV) management—including effective antiretroviral therapy (ART) and long-acting injectables—gaps in screening, testing, and diagnosis continue to limit patient outcomes and prevention efforts. Many clinicians, particularly in primary care and community settings, face challenges integrating evolving global testing guidelines into practice, leading to inconsistent screening, delayed diagnosis, and missed opportunities for rapid linkage to care. These issues are further compounded by stigma, bias, resource limitations, and regional disparities in access to care. To address these barriers, clinicians need practical, regionally relevant education that strengthens their ability to implement evidence-based HIV testing strategies, adopt routine screening, and integrate rapid-start/same-day ART workflows. Equipping clinicians with effective communication techniques and culturally responsive approaches is essential to improving patient engagement, increasing HIV testing uptake, and ultimately reducing HIV transmission and disease burden.
In this CMEO Snack, expert faculty will discuss the role of HIV testing in connecting individuals to the care continuum, with a focus on global testing guidelines. Faculty will also explore strategies for increasing HIV testing uptake across the socioeconomic spectrum by reviewing effective communication approaches to address stigma, bias, and access/resource barriers; comparing testing practices and guideline recommendations by region; and outlining rapid-start and same-day ART initiation workflows following diagnosis.
At the conclusion of this activity, learners will be able to better:
This activity has been supported by an independent educational grant from Gilead Sciences, Inc.
HIV/infectious disease (ID) specialists, primary care practitioners (PCPs), general practitioners (GPs), physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists in key regions globally: United States, Europe, Africa, and Asia
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This application-based activity is approved for 0.75 contact hours (0.075 CEUs) of continuing pharmacy credit (JA0007185-0000-26-084-H01-P).
This activity is designated for 0.75 contact hours.
California Residents: Provider approved by the California Board of Registered Nursing, Provider # CEP 15510, for 0.75 Contact Hours.
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 10/23/2026. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Through a mutual recognition agreement between the AMA and the UEMS-EACCME, European physicians completing an e-learning activity from a US-based ACCME-accredited CME provider can use AMA PRA Category 1 Credit™ toward their credit requirements. CME Outfitters is based in Radnor, Pennsylvania, USA. Please retain your certificate as proof of completion.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Faculty
Dr. Blackstock reports the following financial relationships:
Advisory Board: Health Equity Advisory Board – ViiV Healthcare
Speakers Bureau: Gilead Sciences, Inc. and ViiV Healthcare
Prof. Orkin reports the following financial relationships:
Advisory Board: Gilead Sciences, Inc.; GSK; MSD (Merck Sharp & Dohme); and ViiV Healthcare
Grants: Gilead Sciences, Inc.; GSK; MSD (Merck Sharp & Dohme); and ViiV Healthcare
Speakers Bureau: Bavarian Nordic; Gilead Sciences, Inc.; GSK; MSD (Merck Sharp & Dohme); and ViiV Healthcare
Dr. Solomon reports the following financial relationships:
Advisory Board: Merck & Co., Inc.
Grants: Abbott Laboratories
Research Support: Abbott Laboratories
Other financial or material support: Honorarium from Gilead Sciences, Inc. to serve on a review committee
Dr. Titanji reports no financial relationships to disclose.
Patient Planners
Mr. Raif Derrazi reports the following financial relationships:
Advisory Board: ViiV Healthcare
Other financial or material support: Occasional Partnerships: ViiV Healthcare
Ms. Angelina Namiba reports no financial relationships to disclose.
Mr. Prasanth Veerapandiyan reports no financial relationships to disclose.
The following individuals have no financial relationships to disclose:
Rebecca Vargas-Jackson, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Susan Perry (Planning Committee)
Estelle Perera (Planning Committee)
Andrea Perseghin, EdD (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
*All identified conflicts of interest have been mitigated.
Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.
Call us at 877.CME.PROS (877.263.7767).
SN-310-102326-47